Bausch Health Companies Inc. EBITDA for the year ending December 31, 2024: USD 2.82 B

Bausch Health Companies Inc. EBITDA is USD 2.82 B for the year ending December 31, 2024, a 28.16% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Bausch Health Companies Inc. EBITDA for the year ending December 31, 2023 was USD 2.20 B, a -23.49% change year over year.
  • Bausch Health Companies Inc. EBITDA for the year ending December 31, 2022 was USD 2.88 B, a -11.72% change year over year.
  • Bausch Health Companies Inc. EBITDA for the year ending December 31, 2021 was USD 3.26 B, a 3.89% change year over year.
  • Bausch Health Companies Inc. EBITDA for the year ending December 31, 2020 was USD 3.14 B, a 69.62% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)